NCT03140540

Brief Summary

Transesophageal echocardiography (TEE) as guide for tailoring perioperative fluid therapy to achieve individualized hemodynamic endpoint, target hemodynamic goals of stroke volume index (SVI) greater than 35 mL/m2 and cardiac index greater than 2.5 L/min/m2 and tissue oxygen delivery. Lactate levels as a surrogate indicator of organ perfusion as measured by arterial blood gas analysis intraoperatively, after 12 hours and 48 hrs postoperatively

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 15, 2017

Completed
19 days until next milestone

First Posted

Study publicly available on registry

May 4, 2017

Completed
1.8 years until next milestone

Study Start

First participant enrolled

February 16, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 27, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 27, 2020

Completed
Last Updated

October 26, 2020

Status Verified

October 1, 2020

Enrollment Period

1 year

First QC Date

April 15, 2017

Last Update Submit

October 22, 2020

Conditions

Keywords

Fluid managementgoal-directed therapytransesophageal echocardiography

Outcome Measures

Primary Outcomes (1)

  • Postoperative complications

    The incidence of postoperative complications in percentage

    48 hours

Secondary Outcomes (2)

  • intraoperative fluid

    intraoperative period (hours)

  • median icu stay

    1 week

Study Arms (2)

Group A (stroke volume variation) guided fluid

ACTIVE COMPARATOR

Stroke volume variation guided intraoperative intravenous fluid will be administered.

Other: Stroke volume variation guided intravenous fluid.

Group B(Study group) TEE guided fluid

ACTIVE COMPARATOR

Transesophageal echocardiography will be used to guide the fluid therapy.

Other: TEE guided fluid therapy will be administered

Interventions

Transesophageal echocardiography will be used to guide the fluid therapy. Velocity time integral of aorta \<20 ,200ml colloid bolus to be administered.

Group B(Study group) TEE guided fluid

Active Comparator: Group A control group (SVV guided fluid ) Stroke volume variation guided intraoperative intravenous fluid will be administered. SVV \>10, 200 ml of colloid bolus to be given

Group A (stroke volume variation) guided fluid

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA 1, 2 and 3
  • Undergoing major abdominal oncosurgery

You may not qualify if:

  • Any contraindication for TEE probe insertion as oesophageal varices , oesophageal and gastric carcinoma , severe left ventricular hypertrophy , coagulopathy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rajiv Gandhi Cancer Institute

Delhi, 110085, India

Location

Related Publications (2)

  • Guarracino F. [The role of transesophageal echocardiography in intraoperative hemodynamic monitoring]. Minerva Anestesiol. 2001 Apr;67(4):320-4. Italian.

  • Trinooson CD, Gold ME. Impact of goal-directed perioperative fluid management in high-risk surgical procedures: a literature review. AANA J. 2013 Oct;81(5):357-68.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Masking Details
The intensivist taking care of the patient postoperatively not aware of the intervention
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: TEE as guide for tailoring perioperative fluid therapy to achieve individualized hemodynamic endpoint , target hemodynamic goals of stroke volume index (SVI) greater than 35 mL/m2 and cardiac index greater than 2.5 L/min/m2 and tissue oxygen delivery. Lactate levels as a surrogate indicator of organ perfusion as measured by arterial blood gas analysis intraoperatively , after 12 hours and 48 hrs postoperatively.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 15, 2017

First Posted

May 4, 2017

Study Start

February 16, 2019

Primary Completion

February 27, 2020

Study Completion

February 27, 2020

Last Updated

October 26, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations